@GEHealthCare reverse corporate pitch The company is repositioning itself as an innovation-driven platform investor, using partnerships and targeted capital deployment to accelerate the future of precision medicine and connected care. Where they’re investing: GE HealthCare is seeking technologies that extend its ecosystem beyond imaging hardware into integrated diagnostics, AI-enabled decision support, and care pathway optimization. That means startups building in: -AI & Data Infrastructure – tools that transform raw imaging and clinical data into actionable insights. -Omics Integration – combining genomics, pathology, and imaging for precision diagnosis. -Smart Devices & Sensors – enabling continuous monitoring and predictive analytics. -Workflow Automation & Clinician Support – software that improves throughput, reduces burnout, and increases accuracy. Their strategy is to invest in or partner with ventures that expand the “Digital Thread” linking imaging, diagnostics, and therapeutics through interoperable data systems. Unlike traditional corporate VCs, GE HealthCare emphasizes mutual value creation: startups get access to GE’s regulatory, commercialization, and global distribution muscle; GE gains agility and innovation throughput from the startup ecosystem. In short: GE HealthCare’s investment thesis sits squarely at the intersection of computational biology, AI, and clinical workflow transformation — precisely where medtech and digital health are converging fastest. 📈 Expect them to continue backing technologies that make healthcare more personalized, predictive, and productive, aligning with their long-term strategy of becoming a data-driven precision care company. #mtc25 @MedTechCon